1.Changes of spasmolysant airways in different phrases in asthmatic patients after bronchodilation test
Jianqin WEI ; Zehua DONG ; Jin HUANG
Journal of Jilin University(Medicine Edition) 2006;0(03):-
Objective To explore the linearic regularity of airways′ spasm and spasmolysis in asthmatic patients,and provide theory bases for clinic treatment.Methods After regular bronchodilation test,the pulmonary function in(16 asthmatic) patients and 14 volunteers were examined 15 min,30 min, 1 h,2 h and 4 h later,respectively.The indexes included forced vital capacity(FVC),forced expiratory flow in one second(FEV_1),peak expiratory flow(PEF),maximal midexpiratory flow(MMEF),expiration of 50% FVC(V_(50)) and expiration of 75% FVC(V_(25)).Results 2 h after bronchodilation test,the big airways dilated completely(P
3.Research progress of immunoglobulin receptors as new therapeutic target
Qiong HUANG ; Wensheng CHEN ; Jin DONG ; Yujing WU ; Wei WEI
Chinese Pharmacological Bulletin 2016;(2):155-158
Immunoglobulins ( Ig ) , also called antibodies, are important components in humoral -mediated immunity. Ig can bind with their receptors, called immunoglobulin receptors ( IgR ) , trigger biologic activities respectively. Different sub-types of Igs show different function. And IgRs have been treated as therapeutic targets in inflammation and immunity related dis-eases for many years. This article reviewed the recent progresses in the study of IgR function and its therapeutic role in inflamma-tion and immunity related diseases.
4.Recent progress of targeted small molecular CDK9 degraders based on PROTAC technology
Jin-xiu LI ; He-wei DONG ; Wei HOU
Acta Pharmaceutica Sinica 2022;57(9):2696-2708
CDKs proteins are a kind of cell cycle protein-dependent kinases, which serve as important roles in controlling cell division and transcriptional stages. Among them, CDK9, as a key regulator responsible for the transcriptional elongation of cells, drives the development of various malignant cells and is considered as an important target in the field of anti-tumor drug development. However, the CDK family proteins feature high conservativeness and similarity in structure, leading to the poor selectivity and severe side effects for traditional small-molecular CDK9 inhibitors, which has limited their clinical applications. In view of this, there is an urgent need to investigate CDK9 targets through a novel strategy. The PROTAC is an emerging drug discovery strategy that the degrader could specifically recognize the target protein through indirect linkage with ubiquitin ligases and ultimately eliminate the target protein through the ubiquitination degradation system. This paper provides a brief overview of the structure and function of CDK9 protein, its relationship with the poor prognosis of clinical diseases, as well as the currently reported small molecular inhibitors. The latest research progress on the targeted degradation of CDK9 protein based on PROTAC technology is highlighted. Finally, the development prospects of this target protein in this novel technology field are summarized and prospected, aiming to provide a reference for the development of antitumor drugs in this direction.
5.Analysis of four flavonoids in Lysimachia clethroides using ionic liquid-assisted extraction.
Jin-feng WEI ; Zhi-juan ZHANG ; Dong-dong LI ; Wei LIU ; Wen-yi KANG
China Journal of Chinese Materia Medica 2015;40(7):1305-1310
In order to established a method for simultaneous determination of isoquercitrin, astragaline, quercetin and kaempferol in Lysimachia clethroides, the ionic liquid 1-hexyl-3-methylimidazolium hexafluorophosphate ([HMIM]PF6) methanol was used as the ultrasound-assisted extraction solvent combing with RP-HPLC. A Purospher star RP-C1 column was used with the mobile phase of aceto- nitrile, methanol and 0. 4% phosphate acid by gradient elution at the detection wavelength of 360 nm. The flow rate was 0.7 mL x min(-1), and the column temperature was the room temperature. Under the optimized conditions, the linear ranges were 2.54 x 10(-2)-2. 54, 2.50 x 10(-2)- 2.50, 1.54 x 10(-3)-0.154, 1.49 x 10(-3)-0.149 microg for isoquercitrin, astragaline, quercetin and kaempferol, respectively. The average recoveries of the four constituents were 101.1%, 98.90%, 101.0%, 101.6%, respectively. The method was green, simple, rapid and accurate, and provided a valid method for analysis of isoquercitrin, astragaline, quercetin and kaempferol in L. clethroides.
Chemical Fractionation
;
instrumentation
;
methods
;
Chromatography, High Pressure Liquid
;
Drugs, Chinese Herbal
;
analysis
;
isolation & purification
;
Flavonoids
;
analysis
;
isolation & purification
;
Ionic Liquids
;
chemistry
;
Primulaceae
;
chemistry
6.Stem cell therapy for degenerative disc diseases:present status and prospects
Yichi ZHOU ; Jingfeng LI ; Shishi DONG ; Wei JIN
Chinese Journal of Tissue Engineering Research 2015;(10):1635-1639
BACKGROUND:None of the current treatment strategies has been focused on relieving or reversing the disk degeneration process after degenerative disc diseases. In recent years, more and more scientists try to treat degenerative disc diseases using stem cel therapy. OBJECTIVE:To explore the research status and prospects of stem cel therapy for degenerative disc diseases. METHODS: A computer-based online search of PubMed database between January 2004 and December 2014was performed to search related articles with the key words of “stem cel, intervertebral disk” in English. Literatures related to stem cel therapy for degenerative disc diseases were selected; in the same field, the articles published lately in authoritative journals were preferred. RESULTS AND CONCLUSION: A total of 342 articles were primarily selected, and 43 articles were involved in result analysis according to inclusion criteria. Stem cel therapy is a newly treatment for degenerative disc diseases. Cels appropriate for stem cel therapy include embryonic stem cels, induced pluripotent stem cels, mesenchymal stem cels, human umbilical cord mesenchymal stem cels and chondrocytes or nucleus pulposus cels. Although cel leakage, intervertebral disc infection and tumorigenesis are the main chalenges, stem cel therapy for degenerative disc diseases is promising in the future.
7.Investigation on DNA damage of mouse mononuclear cells in peripheral blood induced by low-dose T-2 toxin and deoxynivalenol alone or in combination
Jin-ling, ZHANG ; Wei, DONG ; Li-hua, WANG
Chinese Journal of Endemiology 2009;28(4):409-412
Objective To investigate the characteristics and extent of mononuclear ceils DNA damage in peripheral blood of mice fed with low dose T-2 toxin and Deoxynivalenol(DON) alone or in combination and to explore the long-term toxicity of the toxin at sub-clinical dose. Methods Eighty female Balb/c mice weighing (14.0 ± 1.5)g 3 weeks after birth were divided randomly into control group, T-2 toxin group, DON group and T-2 toxin combined with DON group according to their body weight, 20 in each group. The mice were injected intraperitoneally T-2 toxin(5 μg·kg-1·d-1), DON(20 μg·kg-1·d-1), T-2 toxin(5 μg·kg-1·d-1) combined with:DON (20μg·kg-1·d-1)respectively,control group were treated by isotonic NaCl. In 16 weeks and 21 weeks of exposure, the tail blood of the mice was collected. The comet rate, tail DNA content,tail length and tail extent moment of mouse mononuclear ceils in peripheral blood was observed using single cell gel electrophoresis(SCGE). Results ① In T-2 toxin group,tail DNA content,tail length and tail extent moment were (27.71 ± 15.85)%, (13.67 ± 5.56)μm, 4.26 ± 3.83 at 16 weeks and (28.38 ± 15.57)%, (13.83 ± 5.47)μm, 4.37 ± 3.82 at 21 weeks, all levels of the indexes increased. In the control group, the corresponding values were (11.87 ± 4.61)%, (10.59±6.70)μm, 1.34±0.98 at 16 weeks and (11.31 ± 3.94)%, (10.83 ± 7.05)μm, 1.29±1.01 at 21 weeks, the differences in the two groups were significant (all P < 0.05) ;②In DON group, the comet rate of cells, tail DNA content and tail extent moment of comet ceils were 5.62%, (28.13 ±13.31)%, 3.39 ± 2.35 at 16 weeks and 7.71%, (29.17 ± 15.12)%, 5.70 ± 4.17 at 21 weeks. In the control group, the tailing rate was 4.34% at 16 weeks and 4.38% at 21 weeks, the differences in the two groups were significant (all P < 0.05);③In the group of T-2 toxin combined with DON,the comet rate, tail DNA content, tail length and tail extent moment was 6.21%, (30.14 ± 15.48)%, (16.93± 6.58)μm, 5.54 ± 4.22 at 16 weeks and 8.17%, (30.85 ± 15.76)%, (17,21±6.45)μm, 5.70 ± 4.17 at 21 weeks. Moreover, the levels were significantly higher than that in the control group(all P < 0.05). The tail DNA content and length of comet cell tail significantly increased in the combine group compared with T-2 group or DON group(P < 0.05). Conclusions Low dose T-2 toxin or DON can definitely result in DNA damage of mononuclear cells in peripheral blood of mice. The damage induced by T-2 toxin combined with DON is severer than that caused by T-2 toxin or DON alone.
8.The impact of combined laparoscopic and choledochoscopic treatment on biliary leak in hepatic hydatid disease in a high attitude region
Jin DONG ; Baobao DANG ; Wei QIN ; Yu HU
Chinese Journal of Hepatobiliary Surgery 2016;22(2):86-89
Objective To explore the impact of combined laparoscopic and choledochoscopic treatment on bile leak in hepatic hydatid disease at a high attitude region.Methods The clinical data of 50 patients who underwent combined laparoscopic and choledochoscopic treatment were compared with 50 patients who underwent laparoscopic surgery alone for hepatic hydatid internal capsule excision surgery.Results In the combined laparoscopic and choledochoscopic group,the incidence of biliary fistula after surgery was 15%,the incision infection rate was 13%,the length of hospitalization was (11.6 ± 3.8) days and the postoperative time to take off drain was (14.3 ± 7.9) days.These were significantly better than those in the laparoscopic alone group.The operation time in the former group was (108.2 ± 28.4)min,which was slightly longer than the laparoscopy group.Conclusion The combined laparoscopic and choledochoscopic treatment is a safer therapeutic option in treating hepatic hydatid disease with less trauma,faster recovery and shorter hospital stay than laparoscopic surgery alone in a high attitude region.
9.Lumbar disc degeneration:tissue engineering repair and biomechanical evaluation
Shishi DONG ; Jingfeng LI ; Yichi ZHOU ; Yuanyu ZHA ; Wei JIN
Chinese Journal of Tissue Engineering Research 2015;(37):6024-6030
BACKGROUND:At present, the clinical treatment of lumbar disc degeneration mainly includes conservative treatment, traditional surgery and minimal y invasive surgery. The therapeutic purpose is to relieve symptoms, but the long-term effect is not very satisfactory. Therapeutic methods focusing on biological functional recovery have been concerned gradual y, but the clinical application is far in sight. OBJECTIVE:To review the advances in the treatment of lumbar disc degeneration regarding tissue-engineered repair and biomechanics. METHODS:PubMed database was searched by the first author for relevant articles published before December 2014 using the keywords of“intervertebral disc degeneration, clinical treatment, biological treatment, tissue engineering, biomechanics, repair, progress”in English. A total of 100 articles were searched initial y and final y, 40 articles were included in result analysis. RESULTS AND CONCLUSION:Although the therapeutic schemes are varied, the treatment of intervertebral disc degeneration is a great chal enge for clinicians and basic researchers. Currently there is no perfect clinical treatment, and indications corresponding to various therapies should be paid attention as wel as long-term fol ow-up evaluation. For various reasons, the biological treatment for intervertebral disc degenerative disease is becoming more and more popular, providing a promising prospect for the treatment of intervertebral disc degeneration. So far, large amounts of data have been obtained from animal experiments, but there are stil many problems to be solved. Other chal enges also involve the al aspects of general tissue engineering methods, such as cel s, cytokines and scaffolds. In these studies, the nucleus pulposus tissue engineering based on the combination of heparin-functionalized chitosan hydrogel, cytokines and stem cel s exhibits a promising prospect.
10.Research progress on hepatic ischemia/reperfusion injury
Yibao DU ; Bo DONG ; Chengguang YANG ; Wei JIN ; Peng SUN
International Journal of Surgery 2015;42(10):713-716
Hepatic ischemia/reperfusion injury is an important restricting factor of clinical liver resection and liver transplantation.When the liver is transiently deprived of blood followed by repeffusion,a large number of various mediators are released that can lead to cellular and,eventually,organ dysfunction.This review summarizes the pathogenesis and the protection mechanisms of hepatic ischemia/reperfusion injury.